Hanmant Gaikwad

机构：CIBBIM-Nanomedicine, University of Colorado Anschutz Medical Campus, University of Montana, University of Colorado Denver · ORCID：0000-0001-5526-0545

发表论文 45 篇 · 总被引 712 次 · h-index 15

代表论文

• Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins (2023 · Nature Nanotechnology · 被引 45)
• Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label (2021 · ACS Nano · 被引 35)
• PEGylated Liposomes Accumulate in the Areas Relevant to Skin Toxicities via Passive Extravasation across “Leaky” Endothelium (2022 · ACS Nano · 被引 27)
• Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro (2021 · Precision Nanomedicine · 被引 20)
• Aggrelyte‐2 promotes protein solubility and decreases lens stiffness through lysine acetylation and disulfide reduction: Implications for treating presbyopia (2023 · Aging Cell · 被引 18)
• Indocarbocyanine nanoparticles extravasate and distribute better than liposomes in brain tumors (2022 · Journal of Controlled Release · 被引 16)